HebeCell and Logomix form a strategic partnership to develop gene-edited NK cells and genetic modifications to create next gen designer NK cells.
HebeCell will attend the Phacilitate Leaders World & World Stem Cell Summit 2020 as an associate sponsor from January 21-24, 2020 in Miami.
As our understanding of stem cell biology surges forward, new investigational therapies are rapidly advancing towards and through clinical trials. This special Toronto event “From Stem Cell Biology to New Therapies” will highlight current clinical applications of stem cell therapies. The program features world-renowned leaders in translational research from academia and industry, and will include an interactive panel that will discuss the regulatory challenges of translational stem cell research.